A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...

By Daphne Psaledakis and Simon Lewis WASHINGTON (Reuters) -About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were ...

You may have heard about Biktarvy, a medicine approved by the FDA in 2018 to treat people with HIV who have not been treated yet. It may also be used to replace another medicine for treating HIV in ...

A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that HIV populations in people with higher viral loads also have higher rates of viral recombination. In ...

The risk of cardiovascular disease is increased among persons with human immunodeficiency virus (HIV) infection, so data regarding primary prevention strategies in this population are needed. In this ...

Brian Zanoni, MD, MPH, discusses forecasts that suggest declining global HIV rates but persistent gaps in care and funding.

Primary effectiveness was measured by the number of patients with HIV-1 RNA ≥50 copies/mL at Week 48, as well as the number of patients with a change in CD4 cell count, and the proportion of patients ...

Since the first case of infection was detected in 1996, the cumulative number of HIV-infected people in Nghe An province is ...

Viral infections, including HIV and influenza, are associated with an increased risk of cardiovascular disease.

Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...